CLOV vs SREA · rev $1.37B vs rev $13.19B
Clover Health Investments Corp (CLOV) versus DBA Sempra 5.750% Junior Subordinated Notes due 2079 (SREA) — a side-by-side from cached financials, not a winner call.
Clover Health Investments Corp (CLOV) is a healthcare plans company listed on US.
DBA Sempra 5.750% Junior Subordinated Notes due 2079 (SREA) common stock listed on US.
Latest reported CLOV revenue for 2024-12-31 was $1.37B. Net income was -$43.0M. Revenue was up 8.8% from 2023-12-31 to 2024-12-31. CLOV currently screens at market cap $1.55B.
Latest reported SREA revenue for 2024-12-31 was $13.19B. Net income was $3.50B. Revenue was down 21.1% from 2023-12-31 to 2024-12-31. SREA currently screens at market cap $0.
CLOV currently screens at market cap $1.55B. SREA currently screens at market cap $0.
Not investment advice. Open the CLOV and SREA stock pages for the full models.
Not investment advice.